- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
U.S. sales boost Nycomed to Queen’s Award
Nycomed Amersham received the Queen’s Award for Enterprise, which is given in recognition for a company’s outstanding achievement in technology, exports, or environmental performance. Queen Elizabeth grants the awards on her April 21st
Nycomed Amersham received the Queens Award for Enterprise, which is given in recognition for a companys outstanding achievement in technology, exports, or environmental performance. Queen Elizabeth grants the awards on her April 21st birthday.
The companys headquarters are located in the U.K. while its North American operations are headquartered in Princeton, NJ.
The companys U.K. imaging business group won the award for its continuous achievement in export sales from 1994 to 1999. During this time, Nycomeds British exports more than doubled. Over half of Nycomeds success came through sales from the U.S. office. Myoview, a heart imaging agent, and OncoSeed, a treatment for prostate cancer, were best-sellers, said Daniel L. Peters, Nycomed Imagings U.S. president. The company has won the Queens Award 14 times in the last 33 years.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
